Intelligence Platform
Patents
Browse 183 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11529381
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus
granted patentUS 11519007
Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy
granted patentUS 11505604
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colo
granted patentUS 11492345
Compounds and their methods of use
granted patentUS 11490643
Lactobacillus casei for treating obesity and associated metabolic disorders
granted patentUS 11478430
Implantable medical devices for extended release of therapeutic agents
granted patentUS 11453861
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted patentUS 11427540
Formulations of T-type calcium channel modulators and methods of use thereof
granted patentUS 11401341
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc
granted patentUS 11400123
Combination product for prophylaxis and treatment of irritable bowel syndrome
granted patentUS 11384335
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted patentUS 11345733
Colon and pancreas cancer specific antigens and antibodies
granted patentUS 11317888
Non-invasive method for pressure measurement
granted patentUS 11286291
Co-stimulatory domains for use in genetically-modified cells
granted patentUS 11278535
Compounds and their methods of use
granted patentUS 11278632
Engineered nucleases useful for treatment of hemophilia A
granted patentUS 11279768
Anti-cancer antibodies, combination therapies, and uses thereof
granted patentUS 11274285
Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genom
granted patentUS 11266693
Nucleic acids encoding engineered meganucleases with recognition sequences found in the hu
granted patentUS 11268065
Genetically-modified cells comprising a modified human T cell receptor alpha constant regi
granted patentUS 11261188
Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and cond
granted patentUS 11225641
Probiotic Bifidobacterium strain
granted patentUS 11191935
Implant delivery system with hydration promotor capability
granted patentUS 11186822
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted